Supplemental material
OncoImmunology
Volume 12, 2023 - Issue 1
Original Research
Novel Fab-peptide-HLA-I fusion proteins for redirecting pre-existing anti-CMV T cell immunity to selectively eliminate carcinoma cells
Isabel BritschDepartment of Surgery, Laboratory for Translational Surgical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
https://orcid.org/0000-0003-4772-9889View further author information
https://orcid.org/0000-0003-4772-9889View further author information, Anne P. van WijngaardenDepartment of Surgery, Laboratory for Translational Surgical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlandshttps://orcid.org/0000-0002-8221-1180View further author information
https://orcid.org/0000-0002-8221-1180View further author information, Xiurong KeDepartment of Surgery, Laboratory for Translational Surgical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlandshttps://orcid.org/0000-0001-8982-0950View further author information
https://orcid.org/0000-0001-8982-0950View further author information, Mark. A.J.M. HendriksDepartment of Surgery, Laboratory for Translational Surgical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlandshttps://orcid.org/0000-0001-7276-4622View further author information
https://orcid.org/0000-0001-7276-4622View further author information, Douwe F. SamploniusDepartment of Surgery, Laboratory for Translational Surgical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlandshttps://orcid.org/0000-0002-0613-7150View further author information
https://orcid.org/0000-0002-0613-7150View further author information, Emily M. PloegDepartment of Surgery, Laboratory for Translational Surgical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlandshttps://orcid.org/0000-0002-0735-2020View further author information
https://orcid.org/0000-0002-0735-2020View further author information & Wijnand HelfrichDepartment of Surgery, Laboratory for Translational Surgical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The NetherlandsCorrespondence[email protected]
https://orcid.org/0000-0001-7004-3995View further author information
https://orcid.org/0000-0001-7004-3995View further author information show all